Subclinical Atrial Fibrillation in Older Patients
- PMID: 28778946
- DOI: 10.1161/CIRCULATIONAHA.117.028845
Subclinical Atrial Fibrillation in Older Patients
Abstract
Background: Long-term continuous electrocardiographic monitoring shows a substantial prevalence of asymptomatic, subclinical atrial fibrillation (SCAF) in patients with pacemakers and patients with cryptogenic stroke. Whether SCAF is also common in other patients without these conditions is unknown.
Methods: We implanted subcutaneous electrocardiographic monitors (St. Jude CONFIRM-AF) in patients ≥65 years of age attending cardiovascular or neurology outpatient clinics if they had no history of atrial fibrillation but had any of the following: CHA2DS2-VASc score of ≥2, sleep apnea, or body mass index >30 kg/m2. Eligibility also required either left atrial enlargement (≥4.4 cm or volume ≥58 mL) or increased (≥290 pg/mL) serum NT-proBNP (N-terminal pro-B-type natriuretic peptide). Patients were monitored for SCAF lasting ≥5 minutes.
Results: Two hundred fifty-six patients were followed up for 16.3±3.8 months. Baseline age was 74±6 years; mean CHA2DS2-VASc score was 4.1±1.4; left atrial diameter averaged 4.7±0.8 cm; and 48% had a prior stroke, transient ischemic attack, or systemic embolism. SCAF ≥5 minutes was detected in 90 patients (detection rate, 34.4%/y; 95% confidence interval [CI], 27.7-42.3). Baseline predictors of SCAF were increased age (hazard ratio [HR] per decade, 1.55; 95% CI, 1.11-2.15), left atrial dimension (HR per centimeter diameter, 1.43; 95% CI, 1.09-1.86), and blood pressure (HR per 10 mm Hg, 0.87; 95% CI, 0.78-0.98), but not prior stroke. The rate of occurrence of SCAF in those with a history of stroke, systemic embolism, or transient ischemic attack was 39.4%/y versus 30.3%/y without (P=0.32). The cumulative SCAF detection rate was higher (51.9%/y) in those with left atrial volume above the median value of 73.5 mL.
Conclusions: SCAF is frequently detected by continuous electrocardiographic monitoring in older patients without a history of atrial fibrillation who are attending outpatient cardiology and neurology clinics. Its clinical significance is unclear.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01694394.
Keywords: atrial fibrillation; monitoring, physiologic; stroke.
© 2017 American Heart Association, Inc.
Comment in
-
Seek and Ye Shall Find Subclinical Atrial Fibrillation in High-Risk Elderly Patients.Circulation. 2017 Oct 3;136(14):1284-1287. doi: 10.1161/CIRCULATIONAHA.117.029397. Circulation. 2017. PMID: 28972061 No abstract available.
Similar articles
-
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.J Am Coll Cardiol. 2018 Jun 12;71(23):2603-2611. doi: 10.1016/j.jacc.2018.03.519. J Am Coll Cardiol. 2018. PMID: 29880119 Clinical Trial.
-
Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.Circulation. 2024 Nov 26;150(22):1747-1755. doi: 10.1161/CIRCULATIONAHA.124.069903. Epub 2024 Sep 4. Circulation. 2024. PMID: 39229707 Clinical Trial.
-
Temporal relationship between subclinical atrial fibrillation and embolic events.Circulation. 2014 May 27;129(21):2094-9. doi: 10.1161/CIRCULATIONAHA.113.007825. Epub 2014 Mar 14. Circulation. 2014. PMID: 24633881 Clinical Trial.
-
Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.Europace. 2015 Oct;17 Suppl 2:ii40-6. doi: 10.1093/europace/euv235. Europace. 2015. PMID: 26842114 Review.
-
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.Medicina (Kaunas). 2019 Sep 20;55(10):611. doi: 10.3390/medicina55100611. Medicina (Kaunas). 2019. PMID: 31547078 Free PMC article. Review.
Cited by
-
Selected Advances in the Anti-arrhythmic Management of Atrial Fibrillation: 2023.J Innov Card Rhythm Manag. 2024 Jan 15;15(1):5728-5734. doi: 10.19102/icrm.2024.15014. eCollection 2024 Jan. J Innov Card Rhythm Manag. 2024. PMID: 38304092 Free PMC article. No abstract available.
-
Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit.Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv4-iv11. doi: 10.1093/eurheartjsupp/suae075. eCollection 2024 Jul. Eur Heart J Suppl. 2024. PMID: 39099575 Free PMC article.
-
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.Eur Heart J. 2024 Dec 7;45(46):4902-4916. doi: 10.1093/eurheartj/ehae596. Eur Heart J. 2024. PMID: 39222018 Free PMC article.
-
The incidence of atrial fibrillation detected by implantable loop recorders: a comparison between patients with and without embolic stroke of undetermined source.Eur Heart J Open. 2024 Sep 1;4(5):oeae061. doi: 10.1093/ehjopen/oeae061. eCollection 2024 Sep. Eur Heart J Open. 2024. PMID: 39219854 Free PMC article.
-
2018 Korean Guideline of Atrial Fibrillation Management.Korean Circ J. 2018 Dec;48(12):1033-1080. doi: 10.4070/kcj.2018.0339. Korean Circ J. 2018. PMID: 30403013 Free PMC article. Review.
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials